Schmitt-Hoffmann A, Roos B, Heep M. , et al.
Single-ascending-dose pharmacokinetics and safety of the novel broad-spectrum antifungal triazole BAL4815 after intravenous infusions (50, 100, and 200 milligrams) and oral administrations (100, 200, and 400 milligrams) of its prodrug, BAL8557, in healthy volunteers.
Antimicrob Agents Chemother 2006;
50 (01) 279-285
Download Bibliographical Data